e-learning
resources
London 2016
Tuesday, 06.09.2016
Asthma: treatment, disease control, and quality of life
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
One-year coverage by inhaled steroids in asthma: French claims data
Laurent Laforest (Lyon, France), Laurent Laforest, Manon Belhassen, Gilles Devouassoux, Alain Didier, Marine Ginoux, Eric Van Ganse
Source:
International Congress 2016 – Asthma: treatment, disease control, and quality of life
Session:
Asthma: treatment, disease control, and quality of life
Session type:
Thematic Poster
Number:
4213
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Laurent Laforest (Lyon, France), Laurent Laforest, Manon Belhassen, Gilles Devouassoux, Alain Didier, Marine Ginoux, Eric Van Ganse. One-year coverage by inhaled steroids in asthma: French claims data. Eur Respir J 2016; 48: Suppl. 60, 4213
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Effectiveness of montelukast on asthma control in infants: A claims data study
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
When needed use of inhaled steroids in children with asthma
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
Pattern of asthma control and inhaled corticosteroid (ICS) use in an Australian asthma population
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013
Oral corticosteroids in asthma exacerbations: Differences between patient-reported data and proxies from claims data
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016
Comparative effectiveness of paediatric asthma step-up options: Increasing ICS dose vs adding separate LABA
Source: International Congress 2014 – Paediatric asthma: what is new for the clinician?
Year: 2014
Trends in the asthma hospitalization rate in the Spanish pediatric population
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
Adherence with inhaled corticosteroids in asthma: Does pregnancy lead to improved adherence?
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014
An overview of patient adherence to asthma medication in Canada
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013
Detection of asthma patient-reported exacerbations during follow-up in the ASTROLAB cohort
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
LATE-BREAKING ABSTRACT: Is treatment with inhaled corticosteroids in asthma associated with hospitalisations because of pneumonia?
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016
A national database study of the effectiveness of switching real-life asthma patients to fostair
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015
Study of antioxidant use in patients with asthma exacerbations
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013
Adherence to inhaled corticosteroids in asthmatic children in Dutch primary care
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015
Asthma prescription trends in the emirate of Abu-Dhabi
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013
The Italian registry for severe/uncontrolled asthma
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016
Estimating severe asthma prevalence in austria using nationwide prescription data
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
The use and abuse of steroids in asthma action plans
Source: International Congress 2015 – Any news from the asthma field?
Year: 2015
Astro-Lab project: Assessment of the safety of long-acting beta agonists (LABAs) in asthma by combining health-care databases and direct patient follow-up: Description of the patient pattern in France and in the United-Kingdom (UK)
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013
Long-acting beta2 agonist without concomitant inhaled corticosteroids in children with asthma in primary care
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
Cost analysis of childhood asthma in Iran: A cost evaluation based on referral center data for asthma and allergies
Source: International Congress 2014 – More paediatric asthma
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept